Litigator of the (Past) Week Runners-Up and Shout-Outs

Accolades  |  July 7, 2026

The AmLaw Litigation Daily

---

Shout-out to a Gibson, Dunn & Crutcher team led by Monica Loseman, Mary Beth Maloney and Jonathan Fortney representing Alcon Research, LLC, in a derivative suit brought by the former CFO and co-founder of Aurion Biotech. Alcon held Series C preferred stock, board rights and consent rights over major corporate actions at Aurion, a life-sciences company developing corneal endothelial cell therapy. Plaintiff David Rostov claimed Aurion wrongfully derailed an IPO potentially valued at hundreds of millions of dollars. But last month, Chancellor Kathaleen McCormick sided with Alcon, finding Rostov’s claim relied on the idea that pursuing an IPO was the “best and only path forward” for Aurion. “Delaware law does not permit the court to substitute Plaintiff’s business judgment for that of the Board,” she wrote. The Gibson Dunn team included of counsel Mark Mixon and associates Jacob Arber, Liesel Schapira, Hazel Granada and Swathi Rajan.

To read the complete article visit Law.com (subscription required)

Reprinted with permission from the July 7, 2026 edition of “The AmLaw Litigation Daily” © 2026 ALM Global Properties, LLC. All rights reserved. Further duplication without permission is prohibited, contact 877-256-2472 or asset-and-logo-licensing@alm.com.